MX350866B - Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes. - Google Patents
Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes.Info
- Publication number
- MX350866B MX350866B MX2014004802A MX2014004802A MX350866B MX 350866 B MX350866 B MX 350866B MX 2014004802 A MX2014004802 A MX 2014004802A MX 2014004802 A MX2014004802 A MX 2014004802A MX 350866 B MX350866 B MX 350866B
- Authority
- MX
- Mexico
- Prior art keywords
- whey protein
- infants
- protein micelles
- diabetes
- risk
- Prior art date
Links
- 108010046377 Whey Proteins Proteins 0.000 title abstract 4
- 102000007544 Whey Proteins Human genes 0.000 title abstract 4
- 239000000693 micelle Substances 0.000 title abstract 4
- 235000021119 whey protein Nutrition 0.000 title abstract 4
- 208000008589 Obesity Diseases 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 235000020824 obesity Nutrition 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000003914 insulin secretion Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pediatric Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a micelas de proteínas del suero de leche para uso en el tratamiento y/o prevención de un trastorno asociado a un aumento en la secreción de insulina y/o concentración plasmática de IGF-1 en un infante en riesgo de desarrollar obesidad o diabetes. La invención también se relaciona a una composición nutricional para infantes que comprende micelas de proteínas del suero de leche. Adicionalmente, la invención se relaciona a un uso no terapéutico de una composición nutricional para infantes, comprendiendo micelas de proteínas del suero de leche.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11186141.5A EP2583562A1 (en) | 2011-10-21 | 2011-10-21 | Use of whey protein micelles for infants at risk of obesity or diabetes |
PCT/EP2012/070718 WO2013057233A1 (en) | 2011-10-21 | 2012-10-19 | Use of whey protein micelles for infants at risk of obesity or diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014004802A MX2014004802A (es) | 2015-12-03 |
MX350866B true MX350866B (es) | 2017-09-22 |
Family
ID=47045036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014004802A MX350866B (es) | 2011-10-21 | 2012-10-19 | Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes. |
Country Status (10)
Country | Link |
---|---|
US (1) | US10028978B2 (es) |
EP (2) | EP2583562A1 (es) |
CN (1) | CN103906440B (es) |
AU (1) | AU2012324887B2 (es) |
BR (1) | BR112014009225A8 (es) |
CL (1) | CL2014000865A1 (es) |
ES (1) | ES2643892T3 (es) |
MX (1) | MX350866B (es) |
RU (1) | RU2616525C2 (es) |
WO (1) | WO2013057233A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011115476A1 (en) | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
SI3091973T1 (sl) * | 2013-11-01 | 2018-10-30 | N.V. Nutricia | Lipidni sestavek za izboljšanje sestave telesa med dohitevanjem rasti |
CN105764355A (zh) * | 2013-11-25 | 2016-07-13 | 雀巢产品技术援助有限公司 | 乳基营养组合物与胃部不适 |
RU2694827C1 (ru) * | 2013-11-29 | 2019-07-17 | Нестек С.А. | Детское питание для улучшения чувствительности к инсулину в дальнейшей жизни |
US11252986B2 (en) | 2013-11-29 | 2022-02-22 | Societe Des Produits Nestle S.A. | Use of nutritional compositions having a low protein amount |
WO2015085555A1 (en) * | 2013-12-12 | 2015-06-18 | Nestec S.A. | Array of age-tailored infant formula with optimum protein content and lactose content |
PL3361885T3 (pl) | 2015-10-15 | 2019-11-29 | Nutricia Nv | Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu |
ES2866349T3 (es) | 2016-12-09 | 2021-10-19 | Nutricia Nv | Composición nutricional para mejorar las membranas celulares |
WO2018130595A1 (en) * | 2017-01-11 | 2018-07-19 | Nestec S.A. | Heat sterilized high protein spoonable nutritional compositions with whey protein which comprises whey protein micelles and a source of casein |
CN110381964A (zh) * | 2017-03-03 | 2019-10-25 | 森永乳业株式会社 | Glp-1分泌促进剂和组合物 |
EP4356961A3 (en) * | 2019-06-13 | 2024-07-31 | Société des Produits Nestlé S.A. | Use of whey protein micelles for controlling postprandial glucose response |
MX2022005462A (es) * | 2019-11-08 | 2022-05-26 | Abbott Lab | Exosomas en polvo aislados de la leche bovina, composiciones alimenticias y metodos. |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2683492B2 (ja) * | 1993-09-07 | 1997-11-26 | 雪印乳業株式会社 | ミセル状ホエー蛋白質、その溶液、その粉末およびミセル状ホエー蛋白質の製造法 |
JP2001513571A (ja) * | 1997-08-29 | 2001-09-04 | ザ リセックス カンパニー インコーポレイテッド | 糖尿病、高血糖症及び低血糖症の治療法 |
DE69904257T2 (de) * | 1999-01-20 | 2003-04-17 | N.V. Nutricia, Zoetermeer | Säuglingsnährpräparat |
DE19906379B4 (de) * | 1999-02-16 | 2006-05-18 | Huss, Manfred | Herstellung eines aggregierten Molkenproteinprodukts |
GB0302929D0 (en) * | 2003-02-10 | 2003-03-12 | Inst Of Child Health | Nutrient composition |
WO2005000325A2 (en) * | 2003-06-30 | 2005-01-06 | Nestec S.A. | Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
CN1860131A (zh) * | 2003-08-30 | 2006-11-08 | 雀巢技术公司 | 来自胶束酪蛋白的酸溶性蛋白质 |
EP1839492B1 (en) | 2006-03-27 | 2011-09-14 | Nestec S.A. | Whey protein micelles |
MY153295A (en) * | 2004-09-29 | 2015-01-29 | Nestec Sa | Nanoparticulated whey proteins |
DE602005026456D1 (de) | 2004-12-27 | 2011-03-31 | Nestec Sa | Verwendung von säuglingsnahrung mit reduziertem proteingehalt |
US20090203592A1 (en) * | 2005-07-01 | 2009-08-13 | N.V. Nutricia | Infant nutrition with hydrolised proteins |
AU2006327995B2 (en) | 2005-12-23 | 2012-09-13 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
DE602006015164D1 (de) * | 2006-03-27 | 2010-08-12 | Nestec Sa | Kosmetische Verwendung von Molkeproteinmizellen |
EP1932437A1 (en) | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
CN101438738A (zh) * | 2007-11-23 | 2009-05-27 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种降血糖的酸奶及其生产方法 |
ES2715783T3 (es) | 2008-10-17 | 2019-06-06 | Nestec Sa | Método para preparar composiciones de proteína de suero de leche y composición obtenible mediante el mismo |
CN102917604B (zh) * | 2010-03-12 | 2015-01-07 | 雀巢产品技术援助有限公司 | 掩蔽营养素味道的组合物及其制备方法 |
-
2011
- 2011-10-21 EP EP11186141.5A patent/EP2583562A1/en not_active Withdrawn
-
2012
- 2012-10-19 MX MX2014004802A patent/MX350866B/es active IP Right Grant
- 2012-10-19 ES ES12775022.2T patent/ES2643892T3/es active Active
- 2012-10-19 WO PCT/EP2012/070718 patent/WO2013057233A1/en active Application Filing
- 2012-10-19 EP EP12775022.2A patent/EP2779846B1/en active Active
- 2012-10-19 AU AU2012324887A patent/AU2012324887B2/en not_active Ceased
- 2012-10-19 US US14/353,206 patent/US10028978B2/en active Active
- 2012-10-19 CN CN201280051740.7A patent/CN103906440B/zh active Active
- 2012-10-19 BR BR112014009225A patent/BR112014009225A8/pt not_active IP Right Cessation
- 2012-10-19 RU RU2014120428A patent/RU2616525C2/ru not_active IP Right Cessation
-
2014
- 2014-04-07 CL CL2014000865A patent/CL2014000865A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2779846A1 (en) | 2014-09-24 |
MX2014004802A (es) | 2015-12-03 |
ES2643892T3 (es) | 2017-11-27 |
AU2012324887B2 (en) | 2015-10-29 |
CL2014000865A1 (es) | 2014-08-18 |
AU2012324887A1 (en) | 2014-04-03 |
EP2779846B1 (en) | 2017-09-06 |
BR112014009225A2 (pt) | 2017-06-13 |
EP2583562A1 (en) | 2013-04-24 |
WO2013057233A1 (en) | 2013-04-25 |
RU2014120428A (ru) | 2015-11-27 |
CN103906440A (zh) | 2014-07-02 |
US20140287056A1 (en) | 2014-09-25 |
BR112014009225A8 (pt) | 2017-06-20 |
US10028978B2 (en) | 2018-07-24 |
RU2616525C2 (ru) | 2017-04-17 |
CN103906440B (zh) | 2016-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX350866B (es) | Uso de micelas de proteina de suero de leche para infantes en riesgo de obesidad o diabetes. | |
MX2014015423A (es) | Analogos de peptido de exedina-4. | |
MX2015008114A (es) | Derivados de exendina-4. | |
PH12015500688A1 (en) | Exendin-4 derivatives as dual glp1/glucagon agonists | |
CL2013000594A1 (es) | Composicion que comprende hidrolizado de proteina en base lactea que proviene del tratamiento de una solucion de un material proteinaceo de base lactea con al menos una endopeptidasa tipo tripsina, y una endopeptidasa tipo quimotripsina; uso de dicha composicion como fórmula infantil o complemento alimenticio para inducción de tolerancia oral en infantes o pacientes que lo necesitan, o para reducir el riesgo de alergias. | |
MX2016013244A (es) | Derivados de exendina-4 como agonistas peptidicos duales del receptor de glp-1/glucagon. | |
MX2016013243A (es) | Agonistas peptídicos duales de los receptores de glp-1/glucagón derivados de la exendina-4. | |
MX2016003945A (es) | Composiciones y formulaciones para la prevencion y tratamiento de la diabetes y la obesidad y los metodos de produccion y uso en el control de la glucosa y calorias. | |
MX366405B (es) | Uso de peptidos glp-1 de accion prolongada. | |
NZ746784A (en) | Glucagon and glp-1 co-agonists for the treatment of obesity | |
MX2013013307A (es) | Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2. | |
EA201791611A1 (ru) | Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида | |
PL2696871T3 (pl) | Aklidyna do zastosowania w poprawie jakości snu u pacjentów ze schorzeniami układu oddechowego | |
BR112014009414A2 (pt) | uso de micelas de proteína de soro do leite para melhorar o perfil de insulina em pacientes diabéti-cos | |
PH12016500950A1 (en) | Infant nutrition for improvement in insulin sensitivity later in life | |
WO2012104838A8 (en) | Use of hgh for the treatment of small for gestational age infants under two years of age | |
TH160951A (th) | การใช้เวย์โปรตีนไมเซลล์สำหรับทารกที่เสี่ยงต่อโรคอ้วนหรือเบาหวาน | |
PH12016502055A1 (en) | Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them | |
MX2019008148A (es) | Uso de peptidos glp-1 de accion prolongada. | |
UA97667U (uk) | Спосіб лікування транзиторної лактазної недостатності у дітей грудного віку | |
MX2014003447A (es) | Solucion nutraceutica a base de inulina de agave y metodo de uso para aliviar los sintomas relacionados con la encefalopatia hepatica en pacientes con cirrosis hepatica. | |
UA101726C2 (ru) | Средство для профилактики и лечения сахарного диабета | |
UA97054C2 (ru) | Способ комплексного лечения больных с зависимостью вследствие употребления психоактивных веществ | |
UA52520U (ru) | Способ лечения нарушений функционального состояния кишечника у новорожденных и детей младенческого возраста | |
UA60147U (ru) | Способ лечения больных хроническим некалькулезным холециститом с сопутствующим ожирением |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |